Evasc Neurovascular nabs $10 mln in Yonghua-led Series A
Vancouver medical device company Evasc Neurovascular Enterprises ULC has raised $10 million in a Series A financing, bringing its total funding to date to $27 million. Yonghua Investment Management, a Chinese private equity firm, led the round and was joined by undisclosed existing investors. Founded in 2008, Evasc is focused on the development of disruptive endovascular treatments for cerebral aneurysms. It plans to use the funds raised for the advancement and commercialization of its eCLIPs system, a device designed to treat 95 percent of cerebral aneurysm cases. Evasc is led by Dr Donald Ricci, the company's president and CEO.
15 June 2017•3 mins read
